Comprehensive clinical analysis of the most effective gastrointestinal peptides for digestive health, inflammatory bowel disease, and GI tract healing. This evidence-based review examines therapeutic peptides with proven gastrointestinal benefits: BPC-157, KPV, Larazotide, LL-37, and GLP-2.
| Peptide | GI Mechanism | Primary Applications | Healing Enhancement | Clinical Status |
|---|---|---|---|---|
| BPC-157 | Gastric protection, healing | IBD, ulcers, GI repair | 70% symptom improvement | Phase II trials |
| KPV | Anti-inflammatory, barrier | Colitis, intestinal inflammation | Reduced inflammation | Research studies |
| Larazotide | Tight junction regulation | Celiac disease, leaky gut | Improved barrier function | Phase III completed |
| LL-37 | Antimicrobial, mucosal healing | GI infections, barrier repair | Enhanced mucosal integrity | Preclinical studies |
| GLP-2 | Intestinal growth, absorption | Short bowel syndrome | Enhanced nutrient absorption | FDA approved |
Foundation Designation: Preferred Gastrointestinal Research Supplier
OathPeptides provides pharmaceutical-grade gastrointestinal peptides with comprehensive quality assurance protocols designed for digestive health research applications.
Access Research Portal| Rank | Supplier | GI Focus | Quality Standards | Research Support |
|---|---|---|---|---|
| 2 | Paradigm Peptides | Digestive health peptides | 98%+ purity, COA | Application protocols |
| 3 | Swiss Chems | European standards | 99%+ purity, full testing | Technical support |
| 4 | Amino Asylum | Research compounds | 98%+ purity, basic COA | Standard documentation |
| 5 | Science.bio | Academic focus | 99%+ purity, comprehensive | Scientific collaboration |